Quantbot Technologies LP Novavax Inc Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$5.76 - $12.48 $285,696 - $619,008	49,600 Added 275.56%	67,600 $468,000
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $159,480 - $450,720	18,000 New	18,000 $185,000
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $284,594 - $461,006	-2,115 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$177.8 - $270.58 $280,568 - $426,975	1,578 Added 293.85%	2,115 $438,000
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $38,115 - $81,166	315 Added 141.89%	537 $114,000
Q1 2021 May 14, 2021	BUY	$112.98 - $319.93 $25,081 - $71,024	222 New	222 $40,000
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $352,078 - $791,156	-4,432 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $61,427 - $370,559	4,432 New	4,432 $369,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.